AGELESS MEDICAL SOLUTIONS LLC – Trademark Portfolio
Entity Type: 16
AGELESS MEDICAL SOLUTIONS LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include REGENOLOGY and AMERICAN ACADEMY OF REGENOLOGY. The owner is based in Gainesville, FL.
Suite A
6224 NW 43rd Street
Gainesville, FL 32653
Showing of trademarks Trademarks
Trademark Classifications
AGELESS MEDICAL SOLUTIONS LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does AGELESS MEDICAL SOLUTIONS LLC have?
AGELESS MEDICAL SOLUTIONS LLC has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.
What trademark classes does AGELESS MEDICAL SOLUTIONS LLC file in?
AGELESS MEDICAL SOLUTIONS LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 35 (Advertising & Business). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are AGELESS MEDICAL SOLUTIONS LLC's most well-known trademarks?
AGELESS MEDICAL SOLUTIONS LLC's registered trademark portfolio includes well-known marks such as REGENOLOGY and AMERICAN ACADEMY OF REGENOLOGY. These are among 2 currently registered trademarks in the portfolio.
What is AGELESS MEDICAL SOLUTIONS LLC's trademark registration success rate?
AGELESS MEDICAL SOLUTIONS LLC has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.